‘We could share our knowledge more with others and apply it more widely,’ said Annetje Ottow, President of the Executive Board, while presenting the new Strategic Plan on the University’s 447th Dies Natalis. The new Strategic Plan therefore focuses o
Rapid developments in cell and gene therapy in research and industry provide remedies to increasingly more patients while offering the potential to decrease the burden on society. NecstGen was founded to support clinicians, academic groups, and small industrial therapy developers globally to bring cell and gene therapies to patients. The collaboration with Cytiva is intended to give clients access to scalable and flexible solutions.
LEIDEN, Netherlands, Jan. 11, 2022 /PRNewswire/ Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases
Several contract development and manufacturing organization (CDMO) supported biopharma projects have been flagged in the past month. We take a closer look.